Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
This reprint describes recent advances made in the field of antifungal development, especially the discovery of new drugs and drug repurposing. The articles presented in this book provide useful information and insight for the development of new antifungal drugs or intervention strategies. The ident...
Saved in:
Other Authors: | , , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_91208 | ||
005 | 20220812 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220812s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-4767-1 | ||
020 | |a 9783036547688 | ||
020 | |a 9783036547671 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-4767-1 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Kim, Jong Heon |4 edt | |
700 | 1 | |a Cheng, Luisa W. |4 edt | |
700 | 1 | |a Land, Kirkwood |4 edt | |
700 | 1 | |a Kim, Jong Heon |4 oth | |
700 | 1 | |a Cheng, Luisa W. |4 oth | |
700 | 1 | |a Land, Kirkwood |4 oth | |
245 | 1 | 0 | |a Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (282 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This reprint describes recent advances made in the field of antifungal development, especially the discovery of new drugs and drug repurposing. The articles presented in this book provide useful information and insight for the development of new antifungal drugs or intervention strategies. The identification of new, safe molecules, and cellular targets, as well as the elucidation of their antifungal mechanisms of action, will further the effective control of fungal pathogens, especially those resistant to current therapeutic agents. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a nanoparticles | ||
653 | |a fungi | ||
653 | |a drug delivery systems | ||
653 | |a marine | ||
653 | |a biological synthesis | ||
653 | |a myconanotechnology | ||
653 | |a canesten | ||
653 | |a clotrimazole | ||
653 | |a vulvovaginal | ||
653 | |a vaginitis | ||
653 | |a mycosis | ||
653 | |a candidosis | ||
653 | |a yeast infection | ||
653 | |a candida | ||
653 | |a candida albicans | ||
653 | |a vaginal health | ||
653 | |a anticandidal activity | ||
653 | |a indazole | ||
653 | |a pyrazole | ||
653 | |a 3-phenyl-1H-indazole | ||
653 | |a drug design | ||
653 | |a acetylsalicylic acid (ASA, aspirin) | ||
653 | |a capsule | ||
653 | |a CAP64 | ||
653 | |a Cryptococcus | ||
653 | |a membrane potential (ΔΨM) | ||
653 | |a photodynamic treatment | ||
653 | |a photosensitiser | ||
653 | |a ultrastructure | ||
653 | |a drug repurposing | ||
653 | |a antifungals | ||
653 | |a repositioning | ||
653 | |a yeasts | ||
653 | |a emerging fungi | ||
653 | |a multidrug resistance | ||
653 | |a therapeutic alternatives | ||
653 | |a new targets | ||
653 | |a Candida auris | ||
653 | |a Aspergillus spp. | ||
653 | |a antifungal | ||
653 | |a beta-glucan | ||
653 | |a polycations | ||
653 | |a Galleria mellonella model | ||
653 | |a retinoids | ||
653 | |a Candida spp. | ||
653 | |a onychomycosis | ||
653 | |a Malassezia spp. | ||
653 | |a dermatophytes | ||
653 | |a microbiology | ||
653 | |a mycology | ||
653 | |a all-trans retinoic acid | ||
653 | |a Acanthamoeba | ||
653 | |a free-living ameba | ||
653 | |a Acanthamoeba keratitis | ||
653 | |a isavuconazonium sulfate | ||
653 | |a cyst | ||
653 | |a drug | ||
653 | |a drug discovery | ||
653 | |a drug targets | ||
653 | |a invasive aspergillosis treatment | ||
653 | |a invasive fungal infections | ||
653 | |a fission yeast | ||
653 | |a cell wall | ||
653 | |a β(1,3)-D-glucan synthase | ||
653 | |a antifungal drugs | ||
653 | |a echinocandin drugs | ||
653 | |a echinocandin resistance | ||
653 | |a Fks resistance hot spots | ||
653 | |a cytokinesis | ||
653 | |a septation | ||
653 | |a cell separation | ||
653 | |a cell integrity | ||
653 | |a cell lysis | ||
653 | |a sporotrichosis | ||
653 | |a Felis catus | ||
653 | |a quinones | ||
653 | |a hydrazones | ||
653 | |a zoonoses | ||
653 | |a host-directed drug therapy | ||
653 | |a azoles | ||
653 | |a polyenes | ||
653 | |a echinocandins | ||
653 | |a viral infections | ||
653 | |a azole | ||
653 | |a synergy | ||
653 | |a resistance | ||
653 | |a Candida | ||
653 | |a natural products | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5854 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/91208 |7 0 |z DOAB: description of the publication |